Thank you.
For Médecins Sans Frontières' viewpoint, we have a certain amount of money to spend on the drugs. We want to treat as many people as possible with quality drugs, so we're going to keep going the generic route. We haven't had enough success in having enough affordable medicines from the brand names to not depend on the generics, so unless there's a fundamental change in the pricing--and we can say with certainty that ad hoc, there have been some good initiatives--it's not the route to go if we're talking about saving lives now, if we're talking about the AIDS pandemic.